Substance / Medication

Pantoprazole sodium sesquihydrate

Overview

Clinical overview including description, indications, and evidence base is pending physician authorship or FDA SPL integration. Graph-derived relationship data is available below.

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Research Evidence

Published studies and systematic reviews

Sort:
Comparative Efficacy of P-CAB vs Proton Pump Inhibitors for Grade C/D Esophagitis: A Systematic Review and Network Meta-analysis.
Zhuang Qianjun, Chen Songfeng, Zhou Xuyu et al. · Am J Gastroenterol · 2024
PMID: 38345252Meta-Analysis
Vonoprazan is superior to lansoprazole for healing of severe but not mild erosive esophagitis: A systematic review with meta-analysis of randomized controlled trials.
Simadibrata Daniel Martin, Lesmana Elvira, Fass Ronnie · J Gastroenterol Hepatol · 2024
PMID: 38353152Meta-Analysis
Risk factors and 26-years worldwide prevalence of endoscopic erosive esophagitis from 1997 to 2022: a meta-analysis.
Witarto Andro Pramana, Witarto Bendix Samarta, Pramudito Shidi Laras et al. · Sci Rep · 2023
PMID: 37709957Meta-AnalysisFull text (PMC)
Solubility measurement and thermodynamic modeling of pantoprazole sodium sesquihydrate in supercritical carbon dioxide.
Sodeifian Gholamhossein, Garlapati Chandrasekhar, Razmimanesh Fariba et al. · Sci Rep · 2022
PMID: 35546179OtherFull text (PMC)
Prospects to the formation and control of potential dimer impurity E of pantoprazole sodium sesquihydrate.
Awasthi Arun Kumar, Kumar Lalit, Tripathi Punit et al. · J Pharm Anal · 2019
PMID: 31297294OtherFull text (PMC)
Assessment of the pharmaceutical quality of marketed enteric coated pantoprazole sodium sesquihydrate products.
Mostafa Haitham F, Ibrahim Mohamed A, Mahrous Gamal M et al. · Saudi Pharm J · 2011
PMID: 23960750OtherFull text (PMC)

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Pantoprazole sodium sesquihydrate (substance)
SNOMED CT
432408008
UMLS CUI
C0771929

Clinical Data

This intervention maps to 3 entities in the Ltrl knowledge graph.

3
Conditions
0
Biomarkers
0
Specialists
0
Symptoms

Data is sourced from SNOMED CT, UMLS, and the Ltrl clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.